Search results
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
AOL· 5 days agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in battling diseases related to diabetes and obesity, lifting the fortunes and expectations for ...
What do weight loss drugs mean for a diet industry built on eating less and exercising more? |...
Texarkana Gazette· 7 days agoEver since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds...